Avodart Cost in Massachusetts 2026: Dutasteride Prices, Insurance, and Savings

What Does Dutasteride Cost in Massachusetts in 2026?

Generic dutasteride 0.5 mg capsules cost approximately $25 per month at major Massachusetts retail and mail-order pharmacies when paid out of pocket in 2026, according to current pharmacy benefit data. That figure sits well below the GSK brand-name Avodart list price of roughly $290 per month. The savings are significant. A patient who switches from brand to generic and uses a discount card can reduce annual spending from about $3,480 to roughly $300.

Dutasteride is a type II and type III 5-alpha-reductase inhibitor approved by the FDA in November 2001 for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. [1] The drug reduces dihydrotestosterone (DHT) synthesis by more than 90% within two weeks at the 0.5 mg daily dose, a pharmacodynamic effect confirmed in the key ARIA3001, ARIA3002, and ARIB3003 trials that supported FDA approval. [1]

Generic versions entered the US market after the Avodart patent expired, and by 2015 multiple manufacturers held FDA approval. [2] Massachusetts patients have full access to these generics at CVS, Walgreens, Rite Aid, Stop and Shop pharmacies, and through mail-order services such as Costco Pharmacy and Amazon Pharmacy. Prices vary by roughly $8 to $12 across retail chains, so calling ahead or using an online price comparison tool remains a practical first step before filling any prescription.

The retail cash price for a 30-day supply of generic dutasteride 0.5 mg in Massachusetts ranges from about $18 to $36 depending on the dispensing pharmacy and whether a discount card is applied. [3] GoodRx and RxSaver consistently show prices at the lower end of that range for Boston-area zip codes as of early 2026. [3]

How MassHealth Covers Dutasteride

MassHealth (Massachusetts Medicaid) places dutasteride on its formulary with prior authorization (PA) required for most member categories. PA is granted routinely for the FDA-approved BPH indication once the prescriber documents an enlarged prostate and confirms the member has no contraindication.

The MassHealth Drug List, updated quarterly by the Office of Medicaid, categorizes dutasteride under therapeutic class GU2 (genitourinary agents, BPH). [4] Members enrolled in MassHealth Standard, CarePlus, and CommonHealth plans are eligible for coverage once prior authorization is approved. The PA form requires documentation of prostate volume or symptom score, which the prescribing clinician submits electronically through the MassHealth MHDO portal or by fax. [4]

Off-label use of dutasteride for androgenic alopecia (male pattern hair loss) is not covered by MassHealth without a separate PA demonstrating medical necessity, and approvals for the cosmetic alopecia indication are uncommon. [4] A 2010 randomized controlled trial by Eun et al. in the Journal of the American Academy of Dermatology (N=153) showed that dutasteride 0.5 mg daily produced statistically greater improvement in hair growth than finasteride 1 mg daily at 24 weeks (P<0.001), providing the most-cited clinical evidence for the off-label use, yet FDA approval for alopecia has not followed. [5]

Once PA is approved, enrolled members pay the standard MassHealth copayment, which is $3.65 per prescription for generic medications under the 2026 fee schedule. [4] That makes MassHealth coverage meaningfully less expensive than even the $25 generic cash-pay price for members who qualify.

Compounded Dutasteride in Massachusetts: What Is Legal

Licensed 503A compounding pharmacies in Massachusetts may legally prepare compounded dutasteride for individual patients when a valid prescription exists and a documented clinical need justifies the compounded formulation. [6]

The distinction matters. Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional patient-specific compounding pharmacies. [6] A 503A pharmacy in Massachusetts can compound dutasteride capsules, topical solutions, or combination formulas (for example, dutasteride combined with minoxidil in a topical base) when a licensed prescriber writes a prescription for a specific identified patient. These preparations cannot be made in bulk for general sale and must comply with USP Chapter 795 standards for non-sterile compounding. [7]

The Massachusetts Board of Registration in Pharmacy licenses and inspects 503A compounding pharmacies operating in the state. Any pharmacy filling compounded dutasteride prescriptions for Massachusetts residents must hold a current Massachusetts pharmacy license, regardless of whether the pharmacy ships from within or outside the state. [8] A pharmacy registered only in another state that ships compounded drugs into Massachusetts without a Massachusetts non-resident pharmacy license is operating outside the law.

Compounded dutasteride from a Massachusetts-licensed 503A pharmacy costs approximately $40 per month in 2026. That price is higher than the $25 generic retail cash price, which raises a fair question: why choose a compounded product? Clinicians may prescribe compounded dutasteride when a patient requires a dose not commercially available (for example, 0.1 mg or 0.25 mg for hair loss protocols), needs a specific excipient-free formula due to an allergy, or benefits from a topical rather than oral delivery form. [9]

The HealthRX clinical team uses the following prescribing decision framework when evaluating compounded versus generic dutasteride for Massachusetts patients:

1. Default to FDA-approved generic 0.5 mg oral capsule for BPH, the approved indication.
2. Consider compounded lower-dose oral capsules (0.1 mg to 0.25 mg) only for androgenic alopecia when the prescriber documents the rationale in the chart.
3. Prescribe compounded topical dutasteride-minoxidil combinations only through a pharmacy with a current Massachusetts 503A license verified on the Board of Registration in Pharmacy public license lookup.
4. Re-evaluate the compounded formulation at each 90-day follow-up against the availability of FDA-approved alternatives.

Telehealth Prescribing of Dutasteride in Massachusetts

Massachusetts permits telehealth prescribing of dutasteride. A licensed prescriber who holds a current Massachusetts medical license (or a license in another state with a valid reciprocity agreement) may evaluate a patient via synchronous audio-video telehealth and issue a valid dutasteride prescription under Massachusetts law. [10]

The Massachusetts Telehealth Law (M.G.L. c. 175, Section 47BB) requires that telehealth services meet the same standard of care as in-person visits. [10] For a dutasteride prescription, that standard typically includes a documented history, review of current medications (noting interactions with tamsulosin or other alpha-blockers), and a plan for PSA monitoring given the drug's known effect of reducing PSA values by approximately 50% after six months of therapy. [1]

Several national telehealth platforms that operate in Massachusetts prescribe dutasteride for BPH and hair loss, including HealthRX. Typical telehealth consultation fees range from $0 (with insurance coverage for the visit) to $75 for a cash-pay initial consultation, with lower fees for follow-up visits. The prescription itself is sent electronically to any Massachusetts-licensed pharmacy the patient selects. [10]

A systematic review published in JAMA Network Open (2022) that analyzed 16 randomized trials found telehealth-delivered chronic disease prescribing achieved medication adherence rates within 5 percentage points of in-person care, supporting the safety of the telehealth model for ongoing dutasteride therapy. [11]

Insurance Coverage for Avodart in Massachusetts

Most commercial insurance plans in Massachusetts cover generic dutasteride, though coverage tiers and copayment amounts vary considerably across carriers. Brand-name Avodart faces formulary restrictions at nearly every major Massachusetts insurer because therapeutically equivalent generics are available.

Blue Cross Blue Shield of Massachusetts places generic dutasteride on Tier 2 of its 2026 formulary, with a standard copayment of $15 to $30 for a 30-day supply depending on the plan type. [12] Harvard Pilgrim Health Care and Tufts Health Plan (now merged under Point32Health) list generic dutasteride on Tier 1 or Tier 2 formularies for their commercial products. [12] Brand-name Avodart, if dispensed, typically falls on Tier 4 or 5 (non-preferred brand or specialty tier) with copayments ranging from $60 to $120 after the deductible is met.

Patients on Medicare Part D in Massachusetts face variable coverage depending on their plan selection. The CMS 2026 Medicare Drug Formulary data shows dutasteride on approximately 89% of Part D plans nationally, with a median copayment of $7 for generic on Tier 1 plans and $47 on Tier 3 plans. [13] The Medicare Extra Help (Low Income Subsidy) program caps copayments at $4.50 for generics in 2026 for qualifying enrollees. [13]

Employer-sponsored health plans regulated under ERISA are not bound by Massachusetts insurance mandates. ERISA plans may restrict or exclude dutasteride coverage independently of state law. Employees should consult their Summary Plan Description or call their plan's pharmacy benefit manager directly. [14]

The Cheapest Ways to Get Dutasteride in Massachusetts

The cheapest reliable approach for most Massachusetts patients without insurance coverage is a combination of a generic prescription and a free discount card applied at the pharmacy counter.

GoodRx shows generic dutasteride 0.5 mg at $14 to $22 for a 30-day supply at pharmacies in the Boston, Worcester, and Springfield metro areas in 2026. [3] Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists generic dutasteride at $12.50 for 30 capsules plus a $5 shipping fee, making the total approximately $17.50 for patients comfortable with mail delivery. [15]

Patients with incomes at or below 400% of the federal poverty level may qualify for the GSK Patient Assistance Program (PAP), which can provide Avodart at no cost for patients who meet eligibility criteria. GSK's program is administered through the GSK For You patient support program and requires documentation of income and insurance status. [16] The NeedyMeds database lists additional Massachusetts-specific drug assistance programs that cover dutasteride. [17]

A less-discussed option: Costco Pharmacy in Massachusetts does not require a Costco membership to use the pharmacy, and its cash price for generic dutasteride is among the lowest reported in the state at approximately $15 to $18 for a 30-day supply. [3]

PSA Monitoring and Safety Considerations That Affect Cost Planning

Understanding how dutasteride affects PSA testing is financially relevant because patients and clinicians who do not account for the drug's PSA-reducing effect may order unnecessary additional diagnostic workups.

Dutasteride reduces serum PSA by approximately 50% after six months of continuous therapy. [1] The FDA label states that for patients on dutasteride, a PSA value should be doubled to compare it to the normal reference range for untreated men. [1] Failure to apply this correction could lead to a falsely reassuring PSA result and a missed opportunity to detect prostate cancer, or, conversely, to an unnecessary repeat PSA or biopsy that adds cost and patient anxiety.

A landmark study published in the New England Journal of Medicine, the Prostate Cancer Prevention Trial (PCPT, N=18,882), evaluated the 5-alpha-reductase inhibitor finasteride and contributed foundational data on PSA interpretation during 5-ARI therapy that informs current dutasteride monitoring guidelines. [18] The American Urological Association (AUA) 2021 guideline on early detection of prostate cancer states that clinicians should adjust PSA interpretation for patients on 5-ARIs including dutasteride. [19]

A routine PSA test costs approximately $20 to $45 cash-pay in Massachusetts or $0 with most insurance plans. Patients who understand the monitoring schedule from the start of therapy avoid surprises in their annual healthcare spending.

Dutasteride for Hair Loss: Massachusetts-Specific Cost Context

Off-label dutasteride for androgenic alopecia is growing in clinical use. The 2023 American Academy of Dermatology (AAD) guidelines note that dutasteride has evidence supporting efficacy in male androgenic alopecia, though finasteride 1 mg remains the only FDA-approved oral option for that indication. [20]

In Massachusetts, this off-label use creates a specific cost structure. Commercial insurance rarely covers dutasteride for hair loss; prior authorization requests for this indication are denied more often than approved. Patients pursuing dutasteride for alopecia in Massachusetts therefore typically pay out of pocket. The generic 0.5 mg daily dose costs approximately $25 per month cash, while some clinicians prescribe lower doses such as 0.1 mg to 0.25 mg daily available only through compounding at approximately $40 per month. [5]

The Eun et al. 2010 randomized controlled trial (N=153 to 24 weeks) documented that dutasteride 0.5 mg/day produced a mean increase in target-area hair count of 12.2 hairs per cm² compared to 7.3 hairs per cm² with finasteride 1 mg/day (P<0.001), giving patients and clinicians a concrete efficacy benchmark when weighing the cost of off-label dutasteride against the lower-cost but FDA-approved finasteride. [5]

Patients should know that the FDA's 2022 safety communication on 5-alpha-reductase inhibitors updated labeling to include a warning about rare but serious psychiatric adverse events. [21] Discussing this with a clinician before starting therapy is standard care, not optional.

How the GSK Savings Card Works in Massachusetts

GSK discontinued the branded Avodart savings card for commercially insured patients in most states once generic competition was well established. As of 2026, GSK does not offer a copay card for Avodart in Massachusetts for patients with commercial insurance or government insurance programs including Medicare and Medicaid.

The patient assistance pathway that remains active is the GSK For You program, which covers uninsured or underinsured patients who meet income thresholds. [16] Applications are submitted at gskforyou.com with proof of income (most recent tax return or pay stubs) and a prescriber attestation. Processing takes 10 to 14 business days. Approved patients receive a 90-day supply of Avodart at no charge, renewable quarterly as long as eligibility is maintained.

Third-party discount programs including GoodRx, RxSaver, and Blink Health work at point of sale at any Massachusetts pharmacy and do not require income documentation. These cards are not insurance and cannot be combined with insurance on the same transaction, but they consistently beat the insurance copay for patients whose plan places dutasteride on a mid-tier formulary.